DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets

June 18, 2014 Leave a comment 6,669 Views

To identify physiological targets of drugs and bioactive small molecules, researchers at The Rockefeller University developed an approach, named DrugTargetSeqR, which combines high-throughput sequencing, computational mutation discovery and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9-based genome editing. They applied this ...

RNA-Seq Blog Transcriptome Research & Industry News

Tag Archives: computational mutation discovery

DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets

Learning to predict RNA sequence expressions from whole slide images

CRIC-seq – global profiling of in-situ RNA–RNA contacts associated with a specific RNA-binding protein

Novel machine-learning algorithm creates atlas of cancer with potential as universal diagnostic platform

Long noncoding RNA profiling may be effective for stratification in pediatric AML

spSeudoMap – cell type mapping of spatial transcriptomics using unmatched single-cell RNA-seq data

SoCube – an innovative end-to-end doublet detection algorithm for analyzing scRNA-seq data

Quantabio adds powerful bead booster chemistry to ultra-fast sparQ RNA-Seq HMR kit